{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:48:58Z","timestamp":1697197738222},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2021,3,24]]},"abstract":"<jats:sec><jats:title \/><jats:p>Cutaneous manifestations due to drugs used in the treatment of gastrointestinal disorders are multiple and common. Adequate diagnosis is of great importance, bearing in mind that the therapeutic regimen depends on its diagnosis. In this review, we provided an overview of the most common drug-induced skin lesions with a detailed explanation of the disease course, presentation and treatment, having in mind that in recent years, novel therapeutic modalities have been introduced in the treatment of various gastrointestinal disorders, and that incidence of cutaneous adverse reactions has been on the rise.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389200221999201116143109","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T08:00:23Z","timestamp":1605600023000},"page":"99-107","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders"],"prefix":"10.2174","volume":"22","author":[{"given":"Milica S.","family":"Lalosevic","sequence":"first","affiliation":[{"name":"Clinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovan","family":"Lalosevic","sequence":"additional","affiliation":[{"name":"Clinic of Dermatovenereology, Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihailo","family":"Stjepanovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Stojkovic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03703.x","volume":"71","author":"Ardern-Jones M.R.","year":"2011","unstructured":"Ardern-Jones M.R.; Friedmann P.S.; Skin manifestations of drug allergy. Br J Clin Pharmacol 2011,71(5),672-683","journal-title":"Br J Clin Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S1081-1206(10)63308-X","volume":"86","author":"Tatum A.J.","year":"2001","unstructured":"Tatum A.J.; Ditto A.M.; Patterson R.; Severe serum sickness-like reaction to oral penicillin drugs: three case reports. Ann Allergy Asthma Immunol 2001,86(3),330-334","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","volume":"73","author":"Zuberbier T.","year":"2018","unstructured":"Zuberbier T.; Aberer W.; Asero R.; Abdul Latiff A.H.; Baker D.; Ballmer-Weber B.; Bernstein J.A.; Bindslev-Jensen C.; Brzoza Z.; Buense Bedrikow R.; Canonica G.W.; Church M.K.; Craig T.; Danilycheva I.V.; Dressler C.; Ensina L.F.; Gim\u00e9nez-Arnau A.; Godse K.; Gon\u00e7alo M.; Grattan C.; Hebert J.; Hide M.; Kaplan A.; Kapp A.; Katelaris C.H.; Kocat\u00fcrk E.; Kulthanan K.; Larenas-Linnemann D.; Leslie T.A.; Magerl M.; Mathelier-Fusade P.; Meshkova R.Y.; Metz M.; Nast A.; Nettis E.; Oude-Elberink H.; Rosumeck S.; Saini S.S.; S\u00e1nchez-Borges M.; Schmid-Grendelmeier P.; Staubach P.; Sussman G.; Toubi E.; Vena G.A.; Vestergaard C.; Wedi B.; Werner R.N.; Zhao Z.; Maurer M.; Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GALEN, IAACI, IADVL, JDA, NVvA, MSAI, \u00d6GDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI\/GALEN\/EDF\/WAO Guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018,73(7),1393-1414","journal-title":"Allergy"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2249.2008.03693.x","volume":"153","author":"Deacock S.J.","year":"2008","unstructured":"Deacock S.J.; An approach to the patient with urticaria. Clin Exp Immunol 2008,153(2),151-161","journal-title":"Clin Exp Immunol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jama.2018.19283","volume":"321","author":"Shenoy E.S.","year":"2019","unstructured":"Shenoy E.S.; Macy E.; Rowe T.; Blumenthal K.G.; Evaluation and management of penicillin allergy: a review. JAMA 2019,321(2),188-199","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0190-9622(03)00846-6","volume":"49","author":"Federman D.G.","year":"2003","unstructured":"Federman D.G.; Kirsner R.S.; Moriarty J.P.; Concato J.; The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003,49(5),861-864","journal-title":"J Am Acad Dermatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000485893","volume":"175","author":"Kohli S.","year":"2018","unstructured":"Kohli S.; Mahajan V.K.; Rana B.S.; Mehta K.S.; Raina R.K.; Chauhan P.S.; Sharma V.; Rawat R.; Clinicoepidemiologic features of chronic urticaria in patients with versus without subclinical Helicobacter pylori infection: a cross-sectional study of 150 patients. Int Arch Allergy Immunol 2018,175(1-2),114-120","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=8","first-page":"e43","volume":"11","author":"Chularojanamontri L.","year":"2012","unstructured":"Chularojanamontri L.; Jiamton S.; Manapajon A.; Suvanasuthi S.; Kulthanan K.; Dhana N.; Jongjarearnprasert K.; Cutaneous reactions to proton pump inhibitors: a case-control study. J Drugs Dermatol 2012,11(10),e43-e47","journal-title":"J Drugs Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/1574886312666170711122341","volume":"12","author":"Turedi O.","year":"2017","unstructured":"Turedi O.; Sozener Z.C.; Kendirlinan R.; Bavbek S.; A case of pantoprazole anaphylaxis with cross reactivity to all proton pump inhibitors: finding a safe alternative. Curr Drug Saf 2017,12(3),198-200","journal-title":"Curr Drug Saf"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","volume":"34","author":"Tursi A.","year":"2002","unstructured":"Tursi A.; Brandimarte G.; Daffin\u00e0 R.; Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002,34(7),510-515","journal-title":"Dig Liver Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jemermed.2013.10.004","volume":"46","author":"Ladizinski B.","year":"2014","unstructured":"Ladizinski B.; Lee K.C.; Infliximab-induced urticaria. J Emerg Med 2014,46(5),691-692","journal-title":"J Emerg Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.anai.2011.11.004","volume":"108","author":"Puxeddu I.","year":"2012","unstructured":"Puxeddu I.; Giori L.; Rocchi V.; Bazzichi L.; Bombardieri S.; Tavoni A.; Migliorini P.; Del Corso I.; Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab. Ann Allergy Asthma Immunol 2012,108(2),123-124","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/ACI.0b013e328355b8d3","volume":"12","author":"Chang Y-S.","year":"2012","unstructured":"Chang Y-S.; Hypersensitivity reactions to proton pump inhibitors. Curr Opin Allergy Clin Immunol 2012,12(4),348-353","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref=14","first-page":"535","volume":"26","author":"Nguyen-Khac E.","year":"2002","unstructured":"Nguyen-Khac E.; Le Baron F.; Thevenot T.; Tiry-Lescut C.; Tiry F.; Angioedema in Crohn\u2019s disease possibly due to mesalazine. Gastroenterol Clin Biol 2002,26(5),535-536","journal-title":"Gastroenterol Clin Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12876-019-1049-2","volume":"19","author":"Xie C.","year":"2019","unstructured":"Xie C.; Quan R.; Hong F.; Zou K.; Yan W.; Fu Y.; The culprit of mesalamine intolerance: case series and literature review. BMC Gastroenterol 2019,19(1),138","journal-title":"BMC Gastroenterol"},{"key":"ref=16","first-page":"214","volume":"59","author":"Maya-Epelstein J.","year":"2012","unstructured":"Maya-Epelstein J.; Morales A.; Del-Rio-Navarro B.; Rosas-Vargas M.\u00c1.; Desensitization protocol to methotrexate. Clinical case. Rev Alerg Mex 2012,59(4),214-217","journal-title":"Rev Alerg Mex"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s15006-019-0453-4","volume":"161","author":"Schnopp C.","year":"2019","unstructured":"Schnopp C.; Weins A.; Differential diagnosis of exanthematous skin eruptions. MMW Fortschr Med 2019,161(8),36-42","journal-title":"MMW Fortschr Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MEG.0000000000000049","volume":"26","author":"Krajcovicova A.","year":"2014","unstructured":"Krajcovicova A.; Hlavaty T.; Zelinkova Z.; Letkovsky J.; Huorka M.; Delayed hypersensitivity reaction after initial dose of infliximab: a case report. Eur J Gastroenterol Hepatol 2014,26(4),485-487","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/j.crohns.2012.10.006","volume":"7","author":"Grosen A.","year":"2013","unstructured":"Grosen A.; Julsgaard M.; Christensen L.A.; Serum sickness-like reaction due to infliximab reintroduction during pregnancy. J Crohn\u2019s Colitis 2013,7(5),e191","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/rheumatology\/kex268","volume":"56","author":"Scherlinger M.","year":"2017","unstructured":"Scherlinger M.; Schaeverbeke T.; Truchetet M-E.; Serum sickness-like disease after switching to biosimilar infliximab. Rheumatology (Oxford) F\u00e9d\u00e9ration Hospitalo Universitaire ACRONIM2017,56(11),2032-2034","journal-title":"Rheumatology (Oxford)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/cod.13351","volume":"81","author":"Ben Fadhel N.","year":"2019","unstructured":"Ben Fadhel N.; Chaabane A.; Ammar H.; Ben Romdhane H.; Soua Y.; Chadli Z.; Zili J.; Boughattas N.A.; Ben Fredj N.; Aouam K.; Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption. Contact Dermat 2019,81(5),336-340","journal-title":"Contact Dermat"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cod.12972","volume":"79","author":"Salman A.","year":"2018","unstructured":"Salman A.; Seckin Gencosmanoglu D.; Alahdab Y.O.; Gim\u00e9nez-Arnau A.M.; Mesalazine-induced bullous fixed drug eruption. Contact Dermat 2018,79(1),34-35","journal-title":"Contact Dermat"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1159\/000248997","volume":"174","author":"Kanwar A.J.","year":"1987","unstructured":"Kanwar A.J.; Singh M.; Yunus M.; Belhaj M.S.; Fixed eruption to sulphasalazine. Dermatologica 1987,174(2)-104","journal-title":"Dermatologica"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0536.1996.tb02161.x","volume":"34","author":"Kawada A.","year":"1996","unstructured":"Kawada A.; Kobayashi T.; Noguchi H.; Hiruma M.; Ishibashi A.; Marshall J.; Fixed drug eruption induced by sulfasalazine. Contact Dermat 1996,34(2),155-156","journal-title":"Contact Dermat"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MIB.0000000000001023","volume":"23","author":"Coward S.","year":"2017","unstructured":"Coward S.; Kuenzig M.E.; Hazlewood G.; Clement F.; McBrien K.; Holmes R.; Panaccione R.; Ghosh S.; Seow C.H.; Rezaie A.; Kaplan G.G.; Comparative effectiveness of mesalamine, sulfasalazine, corticosteroids, and budesonide for the induction of remission in Crohn\u2019s disease: a bayesian network meta-analysis. Inflamm Bowel Dis 2017,23(3),461-472","journal-title":"Inflamm Bowel Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000318008","volume":"221","author":"Boussemart L.","year":"2010","unstructured":"Boussemart L.; Jacobelli S.; Batteux F.; Goulvestre C.; Grange P.; Carlotti A.; Morini J.P.; Gorin I.; Ziza J.M.; Avril M.F.; Dupin N.; Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology 2010,221(3),201-205","journal-title":"Dermatology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0190-9622(96)90073-0","volume":"34","author":"Whitworth J.M.","year":"1996","unstructured":"Whitworth J.M.; Thomas I.; Peltz S.A.; Sullivan B.C.; Wolf A.H.; Cytryn A.S.; Vancomycin-induced linear IgA bullous dermatosis (LABD). J Am Acad Dermatol 1996,34(5 Pt 2),890-891","journal-title":"J Am Acad Dermatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/pmj.78.916.114","volume":"78","author":"Odeh M.","year":"2002","unstructured":"Odeh M.; Lurie M.; Oliven A.; Cutaneous leucocytoclastic vasculitis associated with omeprazole. Postgrad Med J 2002,78(916),114-115","journal-title":"Postgrad Med J"},{"key":"ref=29","first-page":"629","volume":"33","author":"Jacobs-Kosmin D.","year":"2006","unstructured":"Jacobs-Kosmin D.; Derk C.T.; Sandorfi N.; Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 2006,33(3),629-632","journal-title":"J Rheumatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1097\/MJT.0b013e3181b0a713","volume":"17","author":"Muzaffar M.","year":"2010","unstructured":"Muzaffar M.; Taj A.; Sethi N.; Kaw D.; Rapidly progressing glomerulonephritis secondary to henoch-schonlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation. Am J Ther 2010,17(5),e163-e166","journal-title":"Am J Ther"},{"key":"ref=31","first-page":"171","volume":"21","author":"Fayaz M.","year":"2009","unstructured":"Fayaz M.; Sultan A.; Nawaz M.; Sultan N.; Mesalazine-induced eosinophilic variant of Wegener\u2019s granulomatosis in an ulcerative colitis patient. J Ayub Med Coll Abbottabad 2009,21(4),171-173","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref=32","first-page":"S104","volume":"24","author":"Sinico R.A.","year":"2006","unstructured":"Sinico R.A.; Sabadini E.; Maresca A.M.; Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn\u2019s disease and sclerosing cholangitis. Clin Exp Rheumatol 2006,24(2)(Suppl. 41),S104","journal-title":"Clin Exp Rheumatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1053\/j.gastro.2018.01.061","volume":"155","author":"Chebli J.M.F.","year":"2018","unstructured":"Chebli J.M.F.; de Oliveira Moreira B.; da Rocha Ribeiro T.C.; An unusual cause of skin rash in Crohn\u2019s disease. Gastroenterology 2018,155(3),618-620","journal-title":"Gastroenterology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.gastrohep.2017.08.004","volume":"41","author":"Bernardes C.","year":"2018","unstructured":"Bernardes C.; Carvalho D.; Saiote J.; Ramos J.; Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn\u2019s disease: report of three cases. Gastroenterol Hepatol 2018,41(7),442-443","journal-title":"Gastroenterol Hepatol"},{"key":"ref=35","first-page":"E20","volume":"99","author":"Laresche C.","year":"2017","unstructured":"Laresche C.; Locatelli F.; Biver-Dalle C.; Nachury M.; Heyd B.; Koch S.; Aubin F.; Severe Henoch-Sch\u00f6nlein purpura complicating infliximab therapy for ulcerative colitis. Cutis 2017,99(1),E20-E22","journal-title":"Cutis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clindermatol.2016.10.007","volume":"35","author":"Kazandjieva J.","year":"2017","unstructured":"Kazandjieva J.; Tsankov N.; Drug-induced acne. Clin Dermatol 2017,35(2),156-162","journal-title":"Clin Dermatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.revmed.2012.12.004","volume":"34","author":"Guillot B.","year":"2013","unstructured":"Guillot B.; Glucocorticoid-induced cutaneous adverse events. Rev Med Interne 2013,34(5),310-314","journal-title":"Rev Med Interne"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","volume":"379","author":"Zaenglein A.L.","year":"2018","unstructured":"Zaenglein A.L.; Acne Vulgaris. N Engl J Med 2018,379(14),1343-1352","journal-title":"N Engl J Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ejca.2006.11.016","volume":"43","author":"Galimont-Collen A.F.S.","year":"2007","unstructured":"Galimont-Collen A.F.S.; Vos L.E.; Lavrijsen A.P.M.; Ouwerkerk J.; Gelderblom H.; Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer 2007,43(5),845-851","journal-title":"Eur J Cancer"},{"key":"ref=40","first-page":"69","volume":"7","author":"Sun G.","year":"2008","unstructured":"Sun G.; Wasko C.A.; Hsu S.; Acneiform eruption following anti-TNF-alpha treatment: a report of three cases. J Drugs Dermatol 2008,7(1),69-71","journal-title":"J Drugs Dermatol"},{"key":"ref=41","first-page":"13030\/qt0vg996xr","volume":"24","author":"Magdaleno-Tapial J.","year":"2018","unstructured":"Magdaleno-Tapial J.; Ferrer-Guill\u00e9n B.; Valenzuela-O\u00f1ate C.; Esteve- Mart\u00ednez A.; Acneiform eruption induced by vedolizumab. Dermatol Online J 2018,24(10),13030\/qt0vg996xr","journal-title":"Dermatol Online J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1177\/1078155215587542","volume":"22","author":"Kara A.","year":"2016","unstructured":"Kara A.; Alatas E.; Dogan G.; Celik S.Y.; Tanriverdi O.; A first case report of diffuse acneiform eruption caused by capecitabine in a patient with small-cell neuroendocrine lung carcinoma. J Oncol Pharm Pract 2016,22(5),717-719","journal-title":"J Oncol Pharm Pract"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/17512433.2020.1698290","volume":"13","author":"Borucki R.","year":"2020","unstructured":"Borucki R.; Werth V.P.; Cutaneous lupus erythematosus induced by drugs - novel insights. Expert Rev Clin Pharmacol 2020,13(1),35-42","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.autrev.2018.03.016","volume":"17","author":"Vaglio A.","year":"2018","unstructured":"Vaglio A.; Grayson P.C.; Fenaroli P.; Gianfreda D.; Boccaletti V.; Ghiggeri G.M.; Moroni G.; Drug-induced lupus: traditional and new concepts. Autoimmun Rev 2018,17(9),912-918","journal-title":"Autoimmun Rev"},{"key":"ref=45","volume":"180","author":"Skovm\u00f8ller K. B.","year":"2018","unstructured":"Skovm\u00f8ller K. B.; Bygum A.; When drugs induce cutaneous lupus erythematosus. Ugeskr Laeg 2018,180(41)","journal-title":"Ugeskr Laeg"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","volume":"30","author":"He Y.","year":"2018","unstructured":"He Y.; Sawalha A.H.; Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol 2018,30(5),490-497","journal-title":"Curr Opin Rheumatol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12519-018-0191-1","volume":"14","author":"Leung A.K.C.","year":"2018","unstructured":"Leung A.K.C.; Leong K.F.; Lam J.M.; Erythema nodosum. World J Pediatr 2018,14(6),548-554","journal-title":"World J Pediatr"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"E566","DOI":"10.1111\/ans.13507","volume":"88","author":"Toh J.W.T.","year":"2018","unstructured":"Toh J.W.T.; Salindera S.; Sarofim M.; Turner C.; Patapanian H.; An unusual cause of bilateral lower limb pitting oedema: Crohn\u2019s septal panniculitis diagnostic of erythema nodosum. ANZ J Surg 2018,88(6),E566-E567","journal-title":"ANZ J Surg"},{"key":"ref=49","first-page":"263","volume":"149","author":"Borroni G.","year":"2014","unstructured":"Borroni G.; Torti S.; D\u2019Ospina R.M.; Pezzini C.; Drug-induced panniculitides. G Ital Dermatol Venereol 2014,149(2),263-270","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=50","author":"Oakley A.M.","year":"2020","unstructured":"Oakley A.M.; Badri T.; StatPearls StatPearls Publishing: Treasure Island, FL 2020","journal-title":"StatPearls StatPearls Publishing: Treasure Island, FL"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.clindermatol.2016.05.006","volume":"34","author":"Monteiro A.F.","year":"2016","unstructured":"Monteiro A.F.; Rato M.; Martins C.; Drug-induced photosensitivity: Photoallergic and phototoxic reactions. Clin Dermatol 2016,34(5),571-581","journal-title":"Clin Dermatol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000018437","volume":"201","author":"Kondo S.","year":"2000","unstructured":"Kondo S.; Kagaya M.; Yamada Y.; Matsusaka H.; Jimbow K.; UVB photosensitivity due to ranitidine. Dermatology 2000,201(1),71-73","journal-title":"Dermatology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/157488606777934477","volume":"1","author":"Piraccini B.M.","year":"2006","unstructured":"Piraccini B.M.; Iorizzo M.; Rech G.; Tosti A.; Drug-induced hair disorders. Curr Drug Saf 2006,1(3),301-305","journal-title":"Curr Drug Saf"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2165\/00044011-200323090-00008","volume":"23","author":"Chan A.L.F.","year":"2003","unstructured":"Chan A.L.F.; Wang H-Y.; Reversibility of tacrolimus-induced alopecia : a case report and literature review. Clin Drug Investig 2003,23(9),611-614","journal-title":"Clin Drug Investig"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4103\/0378-6323.116728","volume":"79","author":"Kanwar A.J.","year":"2013","unstructured":"Kanwar A.J.; Narang T.; Anagen effluvium. Indian J Dermatol Venereol Leprol 2013,79(5),604-612","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1111\/jdv.15028","volume":"32","author":"Nomura H.","year":"2018","unstructured":"Nomura H.; Kurihara Y.; Saito M.; Fukushima A.; Shintani Y.; Shiiyama R.; Toshima S.; Kamata A.; Yamagami J.; Funakoshi T.; Kameyama K.; Amagai M.; Kubo A.; Umegaki-Arao N.; Azathioprine-induced alopecia and leukopenia associated with NUDT15 polymorphisms. J Eur Acad Dermatol Venereol 2018,32(10),e386-e389","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1157\/13119883","volume":"31","author":"Nantes Castillejo O.","year":"2008","unstructured":"Nantes Castillejo O.; Zozaya Urmeneta J.M.; Valcayo Pe\u00f1alba A.; Mart\u00ednez-Pe\u00f1uela Virseda J.M.; Acute generalized exanthematous pustulosis induced by omeprazole. Gastroenterol Hepatol 2008,31(5),295-298","journal-title":"Gastroenterol Hepatol"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"13030\/qt7046n97m","DOI":"10.5070\/D3231033675","volume":"23","author":"Rocci E.","year":"2017","unstructured":"Rocci E.; Park K.; Hutchens K.; Winterfield L.; First report of mesalamine (5-aminosalicylic acid) as the causative agent in a case of acute generalized exanthamous pustulosis. Dermatol Online J 2017,23(1),13030\/qt7046n97m","journal-title":"Dermatol Online J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1346-8138.1999.tb03488.x","volume":"26","author":"Kawaguchi M.","year":"1999","unstructured":"Kawaguchi M.; Mitsuhashi Y.; Kondo S.; Acute generalized exanthematous pustulosis induced by salazosulfapyridine in a patient with ulcerative colitis. J Dermatol 1999,26(6),359-362","journal-title":"J Dermatol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5826\/dpc.0502a23","volume":"5","author":"Cohen P.R.","year":"2015","unstructured":"Cohen P.R.; Proton pump inhibitor-induced Sweet\u2019s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer. Dermatol Pract Concept 2015,5(2),113-119","journal-title":"Dermatol Pract Concept"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1097\/MJT.0000000000000820","volume":"26","author":"Patel A.V.","year":"2019","unstructured":"Patel A.V.; Jotwani P.M.; Sultan K.S.; Azathioprine-induced sweet syndrome treated with infliximab. Am J Ther 2019,26(5),e616-e617","journal-title":"Am J Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/etm.2015.2926","volume":"11","author":"Qiu Z.","year":"2016","unstructured":"Qiu Z.; Liu H.; He L.; Ma Y.; Song H.; Bai W.; Yu M.; Proton pump inhibitor-induced exfoliative dermatitis: a case report. Exp Ther Med 2016,11(2),543-546","journal-title":"Exp Ther Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/01.mib.0000231569.43065.a4","volume":"12","author":"Iemoli E.","year":"2006","unstructured":"Iemoli E.; Piconi S.; Ardizzone S.; Bianchi Porro G.; Raimond F.; Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid. Inflamm Bowel Dis 2006,12(10),1007-1008","journal-title":"Inflamm Bowel Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1111\/ijd.13273","volume":"55","author":"el-Azhary R.A.","year":"2016","unstructured":"el-Azhary R.A.; Lehman J.S.; Exfoliative erythroderma after tumor necrosis factor-\u03b1 inhibitor therapy. Int J Dermatol 2016,55(4),e214-e215","journal-title":"Int J Dermatol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","volume":"81","author":"Descamps V.","year":"2014","unstructured":"Descamps V.; Ranger-Rogez S.; DRESS syndrome. Joint Bone Spine 2014,81(1),15-21","journal-title":"Joint Bone Spine"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000335612","volume":"97","author":"Mockenhaupt M.","year":"2012","unstructured":"Mockenhaupt M.; Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy 2012,97,1-17","journal-title":"Chem Immunol Allergy"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000335627","volume":"97","author":"Harr T.","year":"2012","unstructured":"Harr T.; French L.E.; Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy 2012,97,149-166","journal-title":"Chem Immunol Allergy"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12788\/j.sder.0058","volume":"33","author":"Mockenhaupt M.","year":"2014","unstructured":"Mockenhaupt M.; Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg 2014,33(1),10-16","journal-title":"Semin Cutan Med Surg"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/ijd.12702","volume":"54","author":"Lalosevic J.","year":"2015","unstructured":"Lalosevic J.; Nikolic M.; Gajic-Veljic M.; Skiljevic D.; Medenica L.; Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience. Int J Dermatol 2015,54(8),978-984","journal-title":"Int J Dermatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","volume":"67","author":"Zhang Y.","year":"2011","unstructured":"Zhang Y.; Wang J.; Zhao L-M.; Peng W.; Shen G-Q.; Xue L.; Zheng X-X.; He X-J.; Gong C-Y.; Miao L-Y.; Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol 2011,67(9),885-887","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"Auquier-Dunant A.","year":"2002","unstructured":"Auquier-Dunant A.; Mockenhaupt M.; Naldi L.; Correia O.; Schr\u00f6der W.; Roujeau J-C.; Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol SCAR Study Group. severe cutaneous adverse reactions2002,138(8),1019-1024","journal-title":"Arch Dermatol"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/188015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/188015\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/188015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T13:41:54Z","timestamp":1697118114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/188015\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,24]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200221999201116143109","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}